Douglas Clary

Douglas Clary has extensive work experience in the pharmaceutical industry. Douglas started their career at SUGEN in 1994 and held the position of Associate Director until 2003. Douglas then joined Exelixis in 2003 and has since held various roles, including Director of Molecular and Cellular Pharmacology, Senior Director of Translational Medicine, Executive Director of Medical Affairs, and currently the VP of Medical Affairs. Throughout their career, they have successfully led teams and played a crucial role in the development of clinical studies and pharmacodynamic assays.

Douglas Clary attended Stanford University from 1984 to 1990, earning a PhD in Biochemistry. Prior to that, they studied at the University of Utah from 1979 to 1984, obtaining a Bachelors degree in Biology.